Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 May 2019
Historique:
received: 30 12 2018
revised: 18 03 2019
accepted: 06 04 2019
pubmed: 10 4 2019
medline: 29 8 2019
entrez: 10 4 2019
Statut: ppublish

Résumé

The aim of this study was to develop an innovative in situ gelling suspension for effective nasal delivery of fluticasone. Pectin, gellan gum and sodium hyaluronate were used as gelling/thickening agents, and Tween 80 as a suspending agent. The influence of the formulation and/or administration parameters on formulation sprayability and nasal deposition was explored with an appropriate experimental design with the range for parameters in the design obtained from previous research and domain knowledge. All formulations exhibited appropriate sprayability and instant gelation upon mixing with simulated nasal fluid exhibiting weak gel properties convenient for nasal delivery. Targeted turbinate deposition depended on administration and formulation parameters, including their interactions. Decrease in the administration angle from horizontal plane, increase in inspiratory flow and presence of sodium hyaluronate significantly increased deposition in turbinate region. Parameters in interactions included concentration of polymers, surfactant and fluticasone, as well as administration angle. Selected formulations with high turbinate deposition exhibited significant increase in viscosity upon gelation, showing potential to prolong the drug retention at the nasal mucosa. The highest effect on the gel viscosity, strength and fluticasone release profile was observed for gellan gum, thus recognised as crucial parameter for the optimisation of overall therapeutic effect.

Identifiants

pubmed: 30965121
pii: S0378-5173(19)30271-6
doi: 10.1016/j.ijpharm.2019.04.015
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Gels 0
Polysaccharides, Bacterial 0
Polysorbates 0
Suspensions 0
gellan gum 7593U09I4D
Pectins 89NA02M4RX
Hyaluronic Acid 9004-61-9
Fluticasone CUT2W21N7U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-456

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Laura Nižić (L)

University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia.

Ivo Ugrina (I)

University of Split, Faculty of Science, Department of Mathematics, Split, Croatia.

Drago Špoljarić (D)

Intellomics d.o.o., Zagreb, Croatia.

Vesna Saršon (V)

Jadran-galenski laboratorij d.d., Rijeka, Croatia.

Maša Safundžić Kučuk (MS)

Jadran-galenski laboratorij d.d., Rijeka, Croatia.

Ivan Pepić (I)

University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia.

Anita Hafner (A)

University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, Zagreb, Croatia. Electronic address: ahafner@pharma.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH